• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Is There Still a Role for Allogeneic Transplantation in the Management of Lymphoma?

作者信息

Shah Nirav N, Hamadani Mehdi

机构信息

Blood and Bone Marrow Transplant and Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, WI.

Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.

出版信息

J Clin Oncol. 2021 Feb 10;39(5):487-498. doi: 10.1200/JCO.20.01447. Epub 2021 Jan 12.

DOI:10.1200/JCO.20.01447
PMID:33434076
Abstract
摘要

相似文献

1
Is There Still a Role for Allogeneic Transplantation in the Management of Lymphoma?异基因移植在淋巴瘤治疗中仍有作用吗？
J Clin Oncol. 2021 Feb 10;39(5):487-498. doi: 10.1200/JCO.20.01447. Epub 2021 Jan 12.
2
Allogeneic hematopoietic stem cell transplantation for lymphoma.淋巴瘤的异基因造血干细胞移植
Clin Lymphoma. 2004 Mar;4(4):238-49. doi: 10.3816/clm.2004.n.004.
3
Chimeric antigen receptor T-cell therapy after allogeneic stem cell transplant for relapsed/refractory large B-cell lymphoma.异基因干细胞移植后嵌合抗原受体T细胞疗法治疗复发/难治性大B细胞淋巴瘤
Br J Haematol. 2021 Jan;192(1):212-216. doi: 10.1111/bjh.17121. Epub 2020 Nov 10.
4
[Malignant lymphoma. Current topics. 2. Hematopoietic stem cell transplantation for malignant lymphoma].[恶性淋巴瘤。当前主题。2. 恶性淋巴瘤的造血干细胞移植]
Nihon Naika Gakkai Zasshi. 2008 Jul 10;97(7):1627-36. doi: 10.2169/naika.97.1627.
5
Allogeneic transplantation following nonmyeloablative conditioning for aggressive lymphoma.非清髓性预处理后异基因移植治疗侵袭性淋巴瘤。
Bone Marrow Transplant. 2008 Aug;42 Suppl 1:S35-S36. doi: 10.1038/bmt.2008.110.
6
Allogeneic Transplantation and Chimeric Antigen Receptor-Engineered T-Cell Therapy for Relapsed or Refractory Mantle Cell Lymphoma.异基因移植和嵌合抗原受体修饰 T 细胞疗法治疗复发或难治性套细胞淋巴瘤。
Hematol Oncol Clin North Am. 2020 Oct;34(5):957-970. doi: 10.1016/j.hoc.2020.06.010. Epub 2020 Aug 1.
7
Allogeneic hematopoietic transplantation for chronic lymphocytic leukemia and lymphoma: potential for nonablative preparative regimens.慢性淋巴细胞白血病和淋巴瘤的异基因造血移植：非清髓预处理方案的潜力
Curr Oncol Rep. 2000 Mar;2(2):182-91. doi: 10.1007/s11912-000-0092-y.
8
CAR T-cell therapy versus allogeneic HSCT for relapsed or refractory mantle cell lymphoma.嵌合抗原受体T细胞疗法与异基因造血干细胞移植治疗复发或难治性套细胞淋巴瘤的比较
Lancet Haematol. 2023 Dec;10(12):e951-e952. doi: 10.1016/S2352-3026(23)00335-6.
9
Allogeneic Hematopoietic Cell Transplantation as Curative Therapy for Patients with Non-Hodgkin Lymphoma: Increasingly Successful Application to Older Patients.异基因造血细胞移植作为非霍奇金淋巴瘤患者的治愈性疗法：在老年患者中的应用日益成功。
Biol Blood Marrow Transplant. 2016 Sep;22(9):1543-1551. doi: 10.1016/j.bbmt.2016.04.019. Epub 2016 Apr 27.
10
[The present and future of allogeneic hematopoietic stem cell transplantation for mantle cell lymphoma].[套细胞淋巴瘤异基因造血干细胞移植的现状与未来]
Zhonghua Nei Ke Za Zhi. 2024 May 1;63(5):512-516. doi: 10.3760/cma.j.cn112138-20231201-00355.

引用本文的文献

1
When to use stem cell transplantation for classical Hodgkin lymphoma.何时将干细胞移植用于经典型霍奇金淋巴瘤。
Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):517-523. doi: 10.1182/hematology.2024000575.
2
High-Dose Chemotherapy and Autologous or Allogeneic Transplantation in Aggressive B-Cell Lymphoma-Is There Still a Role?大剂量化疗联合自体或异基因移植治疗侵袭性 B 细胞淋巴瘤：是否仍有一席之地？
Cells. 2024 Oct 27;13(21):1780. doi: 10.3390/cells13211780.
3
Therapeutic options for large B-cell lymphoma relapsing after CD19-directed CAR T-cell therapy.
CD19 靶向 CAR T 细胞治疗后复发的大 B 细胞淋巴瘤的治疗选择。
Bone Marrow Transplant. 2024 Feb;59(2):162-170. doi: 10.1038/s41409-023-02176-0. Epub 2023 Dec 16.
4
Allogeneic hematopoietic stem cell transplantation for B-cell lymphoma in Taiwan.台湾地区 B 细胞淋巴瘤的异基因造血干细胞移植。
Cancer Med. 2023 Dec;12(24):21761-21769. doi: 10.1002/cam4.6741. Epub 2023 Nov 28.
5
Five-year follow-up of ZUMA-1 supports the curative potential of axicabtagene ciloleucel in refractory large B-cell lymphoma.ZUMA-1 的 5 年随访结果支持 axi-cel 在难治性大 B 细胞淋巴瘤中的治疗潜力。
Blood. 2023 May 11;141(19):2307-2315. doi: 10.1182/blood.2022018893.
6
Fludarabine plus reduced-intensity busulfan versus fludarabine plus myeloablative busulfan in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic cell transplantation.氟达拉滨联合减低强度的白消安与氟达拉滨联合清髓性白消安在非霍奇金淋巴瘤患者异基因造血细胞移植中的比较。
Ann Hematol. 2023 Mar;102(3):651-661. doi: 10.1007/s00277-023-05084-x. Epub 2023 Jan 12.
7
Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide for Peripheral T Cell Lymphoma: The Importance of Graft Source.异基因造血干细胞移植联合移植后环磷酰胺治疗外周 T 细胞淋巴瘤：移植物来源的重要性。
Transplant Cell Ther. 2023 Apr;29(4):267.e1-267.e5. doi: 10.1016/j.jtct.2022.12.009. Epub 2022 Dec 19.
8
Allogeneic haematopoietic cell transplant in patients with relapsed/refractory anaplastic large cell lymphoma.异基因造血细胞移植治疗复发/难治性间变大细胞淋巴瘤。
Br J Haematol. 2023 Jan;200(1):54-63. doi: 10.1111/bjh.18467. Epub 2022 Sep 19.
9
Preliminary Report of the Academic CAR-T (ISIKOK-19) Cell Clinical Trial in Turkey: Characterization of Product and Outcomes of Clinical Application.土耳其学术 CAR-T（ISIKOK-19）细胞临床试验初步报告：产品特征及临床应用结果。
Turk J Haematol. 2022 Aug 25;39(3):206-210. doi: 10.4274/tjh.galenos.2022.2022.0193. Epub 2022 Jul 18.
10
Impact of conditioning regimen intensity on the outcomes of peripheral T-cell lymphoma, anaplastic large cell lymphoma and angioimmunoblastic T-cell lymphoma patients undergoing allogeneic transplant.预处理方案强度对接受异基因移植的外周 T 细胞淋巴瘤、间变大细胞淋巴瘤和血管免疫母细胞 T 细胞淋巴瘤患者结局的影响。
Br J Haematol. 2022 Apr;197(2):212-222. doi: 10.1111/bjh.18052. Epub 2022 Feb 2.